{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:10:03Z","timestamp":1780989003757,"version":"3.54.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2021JJ30931"],"award-info":[{"award-number":["2021JJ30931"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","award":["20210306770"],"award-info":[{"award-number":["20210306770"]}],"id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","award":["202206375025"],"award-info":[{"award-number":["202206375025"]}],"id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.clnesp.2025.03.011","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T20:06:44Z","timestamp":1743019604000},"page":"453-462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Dietary butyric acid intake, kidney function, and survival: The National Health and Nutrition Examination Surveys, 2005\u20132018"],"prefix":"10.1016","volume":"67","author":[{"given":"Wei","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyi","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JunXiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9872-786X","authenticated-orcid":false,"given":"Can","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clnesp.2025.03.011_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","article-title":"Epidemiology of chronic kidney disease: an update 2022","volume":"12","author":"Kovesdy","year":"2022","journal-title":"Kidney Int Suppl"},{"issue":"10225","key":"10.1016\/j.clnesp.2025.03.011_bib2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"National burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Global","year":"2020","journal-title":"Lancet"},{"issue":"10225","key":"10.1016\/j.clnesp.2025.03.011_bib3","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(19)32977-0","article-title":"The global burden of chronic kidney disease","volume":"395","author":"Cockwell","year":"2020","journal-title":"Lancet"},{"issue":"9818","key":"10.1016\/j.clnesp.2025.03.011_bib4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","article-title":"Prevalence of chronic kidney disease in China: a cross-sectional survey","volume":"379","author":"Zhang","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clnesp.2025.03.011_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cells12030412","article-title":"Autophagy as a therapeutic target for chronic kidney disease and the roles of TGF-\u03b21 in autophagy and kidney fibrosis","volume":"12","author":"Ruby","year":"2023","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.clnesp.2025.03.011_bib6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.cmet.2019.08.003","article-title":"Mitochondrial damage and activation of the STING pathway lead to renal inflammation and fibrosis","volume":"30","author":"Chung","year":"2019","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.clnesp.2025.03.011_bib7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2215\/CJN.06840712","article-title":"The USRDS: what you need to know about what it can and can't tell us about ESRD","volume":"8","author":"Foley","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.clnesp.2025.03.011_bib8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/nep.13883","article-title":"Dietary patterns and chronic kidney disease outcomes: a systematic review","volume":"26","author":"Quintela","year":"2021","journal-title":"Nephrology"},{"issue":"3","key":"10.1016\/j.clnesp.2025.03.011_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/nu13030956","article-title":"Nutrition in chronic kidney disease-the role of proteins and specific diets","volume":"13","author":"Apetrii","year":"2021","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.clnesp.2025.03.011_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/nu13061751","article-title":"Potassium metabolism and management in patients with CKD","volume":"13","author":"Yamada","year":"2021","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.clnesp.2025.03.011_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093277","article-title":"Chronic kidney disease: role of diet for a reduction in the severity of the disease","volume":"13","author":"Naber","year":"2021","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.clnesp.2025.03.011_bib12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2169\/internalmedicine.1602-23","article-title":"Dysbiosis of gut microbiota in patients with chronic kidney disease","volume":"63","author":"Yasuno","year":"2024","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.clnesp.2025.03.011_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.clnesp.2025.03.011_bib14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tem.2020.12.003","article-title":"Butyrate in energy metabolism: there is still more to learn","volume":"32","author":"Zhang","year":"2021","journal-title":"Trends Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.clnesp.2025.03.011_bib15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/jn\/134.2.479","article-title":"Microbial degradation products influence colon cancer risk: the butyrate controversy","volume":"134","author":"Lupton","year":"2004","journal-title":"J Nutr"},{"issue":"5","key":"10.1016\/j.clnesp.2025.03.011_bib16","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2011.02.018","article-title":"The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon","volume":"13","author":"Donohoe","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.clnesp.2025.03.011_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nutres.2021.08.007","article-title":"Mechanistic basis and preliminary practice of butyric acid and butyrate sodium to mitigate gut inflammatory diseases: a comprehensive review","volume":"95","author":"Zhang","year":"2021","journal-title":"Nutr Res"},{"issue":"11","key":"10.1016\/j.clnesp.2025.03.011_bib18","doi-asserted-by":"crossref","first-page":"11894","DOI":"10.1096\/fj.201901080R","article-title":"Gut microbial metabolite butyrate protects against proteinuric kidney disease through epigenetic- and GPR109a-mediated mechanisms","volume":"33","author":"Felizardo","year":"2019","journal-title":"FASEB J"},{"issue":"17","key":"10.1016\/j.clnesp.2025.03.011_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176356","article-title":"Short-chain fatty acids and their association with signalling pathways in inflammation, glucose and lipid metabolism","volume":"21","author":"He","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.clnesp.2025.03.011_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/nu15102275","article-title":"Gut microbial metabolite butyrate and its therapeutic role in inflammatory bowel disease: a literature review","volume":"15","author":"Recharla","year":"2023","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.clnesp.2025.03.011_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26030682","article-title":"The protective role of butyrate against obesity and obesity-related diseases","volume":"26","author":"Coppola","year":"2021","journal-title":"Molecules"},{"issue":"13","key":"10.1016\/j.clnesp.2025.03.011_bib22","first-page":"4570","article-title":"Could the use of butyric acid have a positive effect on microbiota and treatment of type 2 diabetes?","volume":"25","author":"Stachowska","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"10.1016\/j.clnesp.2025.03.011_bib23","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3748\/wjg.v17.i12.1519","article-title":"Potential beneficial effects of butyrate in intestinal and extraintestinal diseases","volume":"17","author":"Canani","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.clnesp.2025.03.011_bib24","first-page":"119","article-title":"Determination of butyric acid dosage based on clinical and experimental studies - a literature review","volume":"15","author":"Banasiewicz","year":"2020","journal-title":"Przegl\u0105d Gastroenterol"},{"issue":"6","key":"10.1016\/j.clnesp.2025.03.011_bib25","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3904\/kjim.2020.411","article-title":"The clinical impact of gut microbiota in chronic kidney disease","volume":"35","author":"Kim","year":"2020","journal-title":"Korean J Intern Med"},{"issue":"10","key":"10.1016\/j.clnesp.2025.03.011_bib26","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s10482-016-0737-y","article-title":"A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression","volume":"109","author":"Jiang","year":"2016","journal-title":"Antonie Leeuwenhoek"},{"issue":"6","key":"10.1016\/j.clnesp.2025.03.011_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.36","article-title":"The microbiota and chronic kidney diseases: a double-edged sword","volume":"5","author":"Felizardo","year":"2016","journal-title":"Clin Transl Immunology"},{"issue":"9","key":"10.1016\/j.clnesp.2025.03.011_bib28","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1365-2036.2005.02639.x","article-title":"Oral butyrate for mildly to moderately active Crohn's disease","volume":"22","author":"Di Sabatino","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clnesp.2025.03.011_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113870","article-title":"Maternal treatment with sodium butyrate reduces the development of autism-like traits in mice offspring","volume":"156","author":"Cristiano","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"10.1016\/j.clnesp.2025.03.011_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.44912","article-title":"Therapeutic effects of butyrate on pediatric obesity: a randomized clinical trial","volume":"5","author":"Coppola","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.clnesp.2025.03.011_bib31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00125-019-05073-8","article-title":"Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial","volume":"63","author":"de Groot","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.clnesp.2025.03.011_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1182570","article-title":"Short-chain fatty acids directly exert anti-inflammatory responses in podocytes and tubular epithelial cells exposed to high glucose","volume":"11","author":"Li","year":"2023","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.03.011_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2478\/acph-2023-0008","article-title":"Sodium butyrate attenuate hyperglycemia-induced inflammatory response and renal injury in diabetic mice","volume":"73","author":"Yan","year":"2023","journal-title":"Acta Pharm"},{"key":"10.1016\/j.clnesp.2025.03.011_bib34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/POR.S97310","article-title":"Chronic kidney disease: identification and management in primary care","volume":"7","author":"Fraser","year":"2016","journal-title":"Pragmatic Observational Res"},{"key":"10.1016\/j.clnesp.2025.03.011_bib35","unstructured":"NHANES\u2014About the National Health and Nutrition Examination Survey. Available online: https:\/\/www.cdc.gov\/nchs\/nhanes\/about_nhanes.htm."},{"issue":"7","key":"10.1016\/j.clnesp.2025.03.011_bib36","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2174\/1389203716666150630135720","article-title":"Interaction between microbes and host intestinal health: modulation by dietary nutrients and gut-brain-endocrine-immune Axis","volume":"16","author":"Chen","year":"2015","journal-title":"Curr Protein Pept Sci"},{"issue":"1","key":"10.1016\/j.clnesp.2025.03.011_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02865-0","article-title":"Butyrate producing microbiota are reduced in chronic kidney diseases","volume":"11","author":"Gao","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.clnesp.2025.03.011_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/ajcn\/nqab011","article-title":"Dietary protein intake, kidney function, and survival in a nationally representative cohort","volume":"114","author":"Narasaki","year":"2021","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"10.1016\/j.clnesp.2025.03.011_bib39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","article-title":"Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease","volume":"19","author":"Mitrofanova","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1016\/j.clnesp.2025.03.011_bib40","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41581-018-0072-9","article-title":"Lipid management in patients with chronic kidney disease","volume":"14","author":"Ferro","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"10.1016\/j.clnesp.2025.03.011_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/nu13093138","article-title":"Dietary lipids and dyslipidemia in chronic kidney disease","volume":"13","author":"Kochan","year":"2021","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.clnesp.2025.03.011_bib42","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4093\/dmj.2023.0067","article-title":"Dyslipidemia in patients with chronic kidney disease: an updated overview","volume":"47","author":"Suh","year":"2023","journal-title":"Diabetes Metab J"},{"issue":"9","key":"10.1016\/j.clnesp.2025.03.011_bib43","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1161\/CIRCRESAHA.122.320184","article-title":"Faecalibacterium prausnitzii attenuates CKD via butyrate-renal GPR43 Axis","volume":"131","author":"Li","year":"2022","journal-title":"Circ Res"},{"issue":"24","key":"10.1016\/j.clnesp.2025.03.011_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27248715","article-title":"Sodium butyrate attenuates AGEs-induced oxidative stress and inflammation by inhibiting autophagy and affecting cellular metabolism in THP-1 cells","volume":"27","author":"Yan","year":"2022","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.clnesp.2025.03.011_bib45","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/ndt\/gfy238","article-title":"Sodium butyrate ameliorates insulin resistance and renal failure in CKD rats by modulating intestinal permeability and mucin expression","volume":"34","author":"Gonzalez","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.clnesp.2025.03.011_bib46","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14126","article-title":"Sodium butyrate alleviates LPS-induced kidney injury via inhibiting TLR2\/4 to regulate rBD2 expression","volume":"46","author":"Dou","year":"2022","journal-title":"J Food Biochem"},{"issue":"12","key":"10.1016\/j.clnesp.2025.03.011_bib47","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1136\/gutjnl-2019-319766","article-title":"Aberrant gut microbiota alters host metabolome and impacts renal failure in humans and rodents","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"issue":"17","key":"10.1016\/j.clnesp.2025.03.011_bib48","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1042\/CS20190171","article-title":"Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease","volume":"133","author":"Wang","year":"2019","journal-title":"Clin Sci (Lond)."},{"issue":"1","key":"10.1016\/j.clnesp.2025.03.011_bib49","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1038\/s41598-017-02989-2","article-title":"Alteration of the gut microbiota in Chinese population with chronic kidney disease","volume":"7","author":"Jiang","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.clnesp.2025.03.011_bib50","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41591-019-0458-7","article-title":"Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer","volume":"25","author":"Yachida","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.clnesp.2025.03.011_bib51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12967-018-1756-4","article-title":"Microbiome-metabolome reveals the contribution of gut-kidney axis on kidney disease","volume":"17","author":"Chen","year":"2019","journal-title":"J Transl Med"},{"issue":"4","key":"10.1016\/j.clnesp.2025.03.011_bib52","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/j.apsb.2022.12.010","article-title":"Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota","volume":"13","author":"Pan","year":"2023","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"10.1016\/j.clnesp.2025.03.011_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/nu12040951","article-title":"Oral supplementation of sodium butyrate attenuates the progression of non-alcoholic steatohepatitis","volume":"12","author":"Baumann","year":"2020","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.clnesp.2025.03.011_bib54","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/gutjnl-2017-314050","article-title":"Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit","volume":"67","author":"Li","year":"2018","journal-title":"Gut"},{"issue":"15","key":"10.1016\/j.clnesp.2025.03.011_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/nu16152454","article-title":"Effect of supplementation of a butyrate-based formula in individuals with liver steatosis and metabolic syndrome: a randomized double-blind placebo-controlled clinical trial","volume":"16","author":"Fogacci","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2025.03.011_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107510","article-title":"Butyrate supplementation reduces sarcopenia by repairing neuromuscular junction in patients with chronic obstructive pulmonary disease","volume":"222","author":"Qaisar","year":"2024","journal-title":"Respir Med"},{"issue":"1\u20132","key":"10.1016\/j.clnesp.2025.03.011_bib57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0303-7207(92)90076-I","article-title":"Effects of sodium butyrate on 1,25-dihydroxyvitamin D3 receptor activity in primary chick kidney cells","volume":"84","author":"Maiyar","year":"1992","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"10.1016\/j.clnesp.2025.03.011_bib58","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1007\/s11255-024-04083-9","article-title":"Associations between serum 25-hydroxyvitamin D and prognosis of chronic kidney disease: a prospective cohort study","volume":"56","author":"Mai","year":"2024","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"10.1016\/j.clnesp.2025.03.011_bib59","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3390\/nu12020331","article-title":"Meal frequency and skipping breakfast are associated with chronic kidney disease","volume":"12","author":"Kim","year":"2020","journal-title":"Nutrients"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725001020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725001020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T14:11:54Z","timestamp":1747231914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457725001020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":59,"alternative-id":["S2405457725001020"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.03.011","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dietary butyric acid intake, kidney function, and survival: The National Health and Nutrition Examination Surveys, 2005\u20132018","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}]}}